Avid Bioservices, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of CDMO for the last quarter is 33.81 M USD, and it's 33.16% higher compared to the previous quarter. The net income of Q3 23 is -6.01 M USD.